Skip to content
Search
About Sakar
Key Milestones / History
Mission, Vision & Values
Management Desk
Rewards & Recognitions
Business
Facility
Exports
Research & Development
Quality
Future Plans
Corporate Social Responsibility
General Product
Oral – Liquid Syrup & Suspension
Liquid Injectable (Svp) – Vials & Ampoules
Cephalosporin – Dry Powder Injections
Cephalosporin – Oral Solid
Lyophilised Injections (In Vials)
Oncology Product
Oral (Tablet, Capsule, Granules & Liquid)
Liquid Injection
Lyophilised Injection
Active Pharmaceutical Ingredient(Api)
CDMO Products
CRAMs
Clients
Investor Relations
Financial Reports (Quarterly & Annually)
Quarterly
Financial Results
Investor Presentation
Earning Audio Call Recording
Earning Call Transcript
Shareholding Pattern
Press Release
Earnings call Invite
Factsheet (Quarterly/Annually)
Annual
Annual Report
Subsidiary financials
Quarterty
Annually
Board of Directors
Board of Directors
Committees
Shareholder’s Information
Share Price Information From BSE & NSE
Notices and Intimations
Corporate Announcement
Shareholder’s Meet / AGM
Credit Rating
Policies
Corporate Governance
Corporate Governance Report
Appointment of Committee Members, Key Managerial Positions
Documents related to Corporate governance, Compliance
Board of Directors
Board Of Directors
Event Calendar
Investor Support
Registrar, Company Secretary and Transfer Agent Information
Grievance Redressal
Reverse Enquiry Toolkit
News & Award
Rewards & Recognitions
Careers
Contact Us
About Sakar
Key Milestones / History
Mission, Vision & Values
Management Desk
Rewards & Recognitions
Business
Facility
Exports
Research & Development
Quality
Future Plans
Corporate Social Responsibility
General Product
Oral – Liquid Syrup & Suspension
Liquid Injectable (Svp) – Vials & Ampoules
Cephalosporin – Dry Powder Injections
Cephalosporin – Oral Solid
Lyophilised Injections (In Vials)
Oncology Product
Oral (Tablet, Capsule, Granules & Liquid)
Liquid Injection
Lyophilised Injection
Active Pharmaceutical Ingredient(Api)
CDMO Products
CRAMs
Clients
Investor Relations
Financial Reports (Quarterly & Annually)
Quarterly
Financial Results
Investor Presentation
Earning Audio Call Recording
Earning Call Transcript
Shareholding Pattern
Press Release
Earnings call Invite
Factsheet (Quarterly/Annually)
Annual
Annual Report
Subsidiary financials
Quarterty
Annually
Board of Directors
Board of Directors
Committees
Shareholder’s Information
Share Price Information From BSE & NSE
Notices and Intimations
Corporate Announcement
Shareholder’s Meet / AGM
Credit Rating
Policies
Corporate Governance
Corporate Governance Report
Appointment of Committee Members, Key Managerial Positions
Documents related to Corporate governance, Compliance
Board of Directors
Board Of Directors
Event Calendar
Investor Support
Registrar, Company Secretary and Transfer Agent Information
Grievance Redressal
Reverse Enquiry Toolkit
News & Award
Rewards & Recognitions
Careers
Contact Us
Growth Beyond Boundaries
To align ourselves with mission of delivering world-class healthcare that remains at the heart of our vision we intend to:
Commercialise Lyophilised products across regions
Mapping growth curve for selective registered products
Procure Marketing Authorizations to expand globally
Establish Strategic Joint ventures to explore depth of markets
Expand through Merger & Acquisitions
Target specific product portfolio through market segmentation
Operate multi-nationally
Profile
About Us
Mission, Vision & Values
Exports
Future Plans
Corporate Social Responsibility
Future Plans
To align ourselves with mission of delivering world-class healthcare that remains at the heart of our vision we intend to:
Commercialise Lyophilised products across regions
Mapping growth curve for selective registered products
Procure Marketing Authorizations to expand globally
Establish Strategic Joint ventures to explore depth of markets
Expand through Merger & Acquisitions
Target specific product portfolio through market segmentation
Operate multi-nationally